Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluation of a Desipramine Ceiling in Cocaine Abuse - 1
This study has been completed.
Study NCT00000245   Information provided by National Institute on Drug Abuse (NIDA)
First Received: September 20, 1999   Last Updated: August 16, 2005   History of Changes

September 20, 1999
August 16, 2005
May 1994
 
  • Craving
  • Retention
  • Cocaine use
  • Depression
  • Anxiety
  • Mood indicators
Same as current
Complete list of historical versions of study NCT00000245 on ClinicalTrials.gov Archive Site
 
 
 
Evaluation of a Desipramine Ceiling in Cocaine Abuse - 1
Evaluation of a Desipramine Ceiling in Cocaine Abuse

The purpose of this study is to confirm whether a blood level ""ceiling"" exists on desipramine effect in cocaine abuse.

 
Phase II
Interventional
Treatment
  • Cocaine-Related Disorders
  • Substance-Related Disorders
Drug: Desipramine
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
0
December 2001
 

Please contact site for information.

Both
18 Years to 65 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00000245
 
NIDA-08082-1, R01-08082-1
National Institute on Drug Abuse (NIDA)
Friends Research Institute, Inc.
Principal Investigator: Frank Gawin, M.D. Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA)
May 1994

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP